Method and device for determining a light transport parameter in a biological matrix
    25.
    发明授权
    Method and device for determining a light transport parameter in a biological matrix 有权
    用于确定生物矩阵中的光传输参数的方法和装置

    公开(公告)号:US07315752B2

    公开(公告)日:2008-01-01

    申请号:US10499109

    申请日:2002-12-07

    IPC分类号: A61B5/00

    摘要: A method for the selective determination of the scattering index μs of a scattering biological matrix, in particular for the purpose of non-invasive determination of the concentration of glucose in the skin, by means of detection measurements, in each of which light in the form of primary light (9) is irradiated into the biological matrix (5) and an intensity measurement value of secondary light (12) exiting at a detection site (33-40) that is located at different measuring distances (ρ) from the respective light irradiation site (10) during the detection measurements is measured. In order to improve the quality and selectivity of the determination of μs, the primary light is irradiated obliquely at an angle between 5° and 85° using a contacting light-guiding element. In at least two detection measurements, the measuring distance (ρ) between the respective light irradiation site (10) and the respective detection site (33-40) corresponds to no more than five times the mean free path length of the light propagating in the biological matrix.

    摘要翻译: 用于通过检测测量法选择性地确定散射生物基质的散射指数的方法,特别是用于非侵入性地测定皮肤中葡萄糖浓度的目的, 其中以原色光(9)的形式的光照射到生物基质(5)中,并且在位于不同测量点处的检测位置(33-40)处出射的次级光(12)的强度测量值 在检测测量期间测量来自相应的光照射部位(10)的距离(rho)。 为了提高测定的质量和选择性,使用接触光引导元件以5°和85°之间的角度倾斜地照射一次光。 在至少两次检测测量中,相应的光照射部位(10)和各个检测部位(33-40)之间的测量距离(rho)对应于不超过在 生物基质。

    Method and device for determining a light transport parameter in a biological matrix
    26.
    发明申请
    Method and device for determining a light transport parameter in a biological matrix 有权
    用于确定生物矩阵中的光传输参数的方法和装置

    公开(公告)号:US20050002031A1

    公开(公告)日:2005-01-06

    申请号:US10499109

    申请日:2002-12-07

    摘要: A method for the selective determination of the scattering index μs of a scattering biological matrix, in particular for the purpose of non-invasive determination of the concentration of glucose in the skin, by means of detection measurements, in each of which light in the form of primary light (9) is irradiated into the biological matrix (5) and an intensity measurement value of secondary light (12) exiting at a detection site (33-40) that is located at different measuring distances (ρ) from the respective light irradiation site (10) during the detection measurements is measured. In order to improve the quality and selectivity of the determination of μs, the primary light is irradiated obliquely at an angle between 5° and 85° using a contacting light-guiding element. In at least two detection measurements, the measuring distance (ρ) between the respective light irradiation site (10) and the respective detection site (33-40) corresponds to no more than five times the mean free path length of the light propagating in the biological matrix.

    摘要翻译: 一种用于选择性地确定散射生物基质的散射指数的方法,特别是通过检测测量来非侵入性地测定皮肤中葡萄糖浓度的目的,其中每种形式的光都是 的初级光(9)照射到生物基质(5)中,并且从位于与各个光的不同测量距离(rho)处的检测位置(33-40)处出射的次级光(12)的强度测量值 在检测测量期间测量照射部位(10)。 为了提高测定的质量和选择性,使用接触光引导元件以5°和85°之间的角度倾斜地照射一次光。 在至少两次检测测量中,相应的光照射部位(10)和各个检测部位(33-40)之间的测量距离(rho)对应于不超过在 生物基质。

    Quantification of disease progression by means of interpolation between parameters based on electromagnetic spectra
    27.
    发明授权
    Quantification of disease progression by means of interpolation between parameters based on electromagnetic spectra 失效
    通过基于电磁波谱的参数之间的插值来定量疾病进展

    公开(公告)号:US07369952B2

    公开(公告)日:2008-05-06

    申请号:US10552248

    申请日:2004-04-06

    IPC分类号: G01R23/16 G06F19/00

    CPC分类号: G16H10/40 G06F19/00 G16H50/50

    摘要: The invention relates to analysis methods for diagnosing diseases on human and animal samples. Said invention also relates to an evaluation method for diagnosing the individual stages of a disease in such a way that it is possible to display the progression thereof. Said invention also makes it possible to identify diseases in an early manner and to carry out therapeutic controls. The inventive method consists in carrying out actually known multivariable evaluation methods for classifying samples. Nevertheless, the invention is characterised in that no sample is allocated to a certain class, but it is classified in a data record based on the interpolation between different classes.

    摘要翻译: 本发明涉及用于诊断人和动物样品疾病的分析方法。 本发明还涉及用于诊断疾病的各个阶段的评估方法,使得可以显示其进展。 所述发明还能够以早期的方式鉴定疾病并进行治疗控制。 本发明的方法在于实现用于分类样品的实际已知的多变量评价方法。 然而,本发明的特征在于,没有将样本分配给某一类,而是基于不同类之间的插值将其分类到数据记录中。

    Control for a disease progression
    28.
    发明申请
    Control for a disease progression 失效
    控制疾病进展

    公开(公告)号:US20060195296A1

    公开(公告)日:2006-08-31

    申请号:US10552248

    申请日:2004-04-06

    IPC分类号: G06F11/30 G06F15/00

    CPC分类号: G16H10/40 G06F19/00 G16H50/50

    摘要: The invention relates to analysis methods for diagnosing diseases on human and animal samples. Said invention also relates to an evaluation method for diagnosing the individual stages of a disease in such a way that it is possible to display the progression thereof. Said invention also makes it possible to identify diseases in an early manner and to carry out therapeutic controls. The inventive method consists in carrying out actually known multivariable evaluation methods for classifying samples. Nevertheless, the invention is characterised in that no sample is allocated to a certain class, but it is classified in a data record based on the interpolation between different classes.

    摘要翻译: 本发明涉及用于诊断人和动物样品疾病的分析方法。 本发明还涉及用于诊断疾病的各个阶段的评估方法,使得可以显示其进展。 所述发明还能够以早期的方式鉴定疾病并进行治疗控制。 本发明的方法在于实现用于分类样品的实际已知的多变量评价方法。 然而,本发明的特征在于,没有将样本分配给某一类,而是基于不同类之间的插值将其分类到数据记录中。